GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » Price-to-Free-Cash-Flow

Pro-Dex (Pro-Dex) Price-to-Free-Cash-Flow : 22.23 (As of May. 02, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Pro-Dex Price-to-Free-Cash-Flow?

As of today (2024-05-02), Pro-Dex's share price is $18.61. Pro-Dex's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.84. Hence, Pro-Dex's Price-to-Free-Cash-Flow Ratio for today is 22.23.

The historical rank and industry rank for Pro-Dex's Price-to-Free-Cash-Flow or its related term are showing as below:

PDEX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.99   Med: 22.06   Max: 195.33
Current: 22.23

During the past 13 years, Pro-Dex's highest Price-to-Free-Cash-Flow Ratio was 195.33. The lowest was 6.99. And the median was 22.06.

PDEX's Price-to-Free-Cash-Flow is ranked better than
65.17% of 333 companies
in the Medical Devices & Instruments industry
Industry Median: 32.03 vs PDEX: 22.23

Pro-Dex's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.84.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 4.70% per year.

During the past 13 years, Pro-Dex's highest 3-Year average Free Cash Flow per Share Growth Rate was 143.80% per year. The lowest was -60.50% per year. And the median was 2.10% per year.


Pro-Dex Price-to-Free-Cash-Flow Historical Data

The historical data trend for Pro-Dex's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Price-to-Free-Cash-Flow Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.91 16.59 - - 15.48

Pro-Dex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 15.48 27.64 20.93

Competitive Comparison of Pro-Dex's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Pro-Dex's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Price-to-Free-Cash-Flow falls into.



Pro-Dex Price-to-Free-Cash-Flow Calculation

Pro-Dex's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=18.61/0.837
=22.23

Pro-Dex's Share Price of today is $18.61.
Pro-Dex's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Pro-Dex  (NAS:PDEX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Pro-Dex Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (Pro-Dex) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
Executives
Angelita Rebamontan Domingo director 1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr director, officer: Chief Executive Officer 34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer director 5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii director 20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg 10 percent owner 12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton officer: Chief Financial Officer 25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot director 3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda director
Farnam Street Partners Lp /mn 10 percent owner 3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder director 1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey director 101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot director P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac director 36 WHISPER DRIVE, WORCESTER MA 01609